Asia Pacific Dermal Fillers Treatment Market is forecast to record an increase in revenue from US$ 810.3 Million in 2021 to US$ 1,650.3 Million by 2030. The market is growing at a CAGR of 8.9% during the forecast period from 2022 to 2030. In terms of volume, the market is expected to grow at a CAGR of 8.0% over the forecast period.
Request Sample Copy of Research Report @ https://www.astuteanalytica.com/request-sample/asia-pacific-dermal-fillers-treatment-market
The market may help from the growing need for Asia’s population to appear young and healthy. People in Asia of all ages are growing increasingly conscious of their appearance and facial features. The well-known hub or center for cosmetic surgery is Asia Pacific. According to the State Administration for Market Regulations, China added 5,510 new medical and beauty institutes in 2020, accounting for 17% of the worldwide market. Additionally, Chinese women spend 2.42 billion dollars annually to improve their aesthetic beauty and change how they seem.
Dermal fillers, which are injected into wrinkles to diminish their appearance, are made of two substances: hyaluronic acid and collagen, both of which are naturally found in the connective tissue of the skin. They have a physical effect rather than a pharmacological, metabolic, or immunological one. The chemicals make the skin more voluminous and less wrinkly by binding water. Additionally, normal connective tissue contains them. The body completely breaks them down over several months.
Factors Contributing to the Market Growth
Celebrity culture’s expanding effect on young people
The demand for dermal fillers and other cosmetic operations is indirectly influenced by celebrities’ growing influence on young people and teenagers around the world. For instance, the Ideal to Real body image poll conducted by Aol.com and Today Show found that over 50% of young females felt disappointed with their appearance since 80% of them compare their appearance to that of celebrities.
A rise in cosmetic surgery treatments
The growth rate is significantly influenced by the increasing use of medical aesthetic operations. Due to the availability of affordable skincare options, increased consumer spending on health and beauty, and a rise in the number of wellness centers and skin care clinics, there may be room for expansion in the Asia Pacific dermal fillers treatment market. According to the State Administration for Market Regulations (SAMR), China added 5,510 new medical and beauty institutes in 2020, accounting for 17% of the worldwide market. Furthermore, Chinese women spend about US$ 2.42 billion annually to improve their aesthetic beauty and change how they seem.
Modernization of the latest dermal fillers
Dermal fillers are injectable gel-like substances used to restore lost volume and smooth out creases and wrinkles beneath the skin. Each year, more than a million people select this well-known cosmetic operation to enhance their facial characteristics by getting rid of wrinkles and improving the look of facial lines. With dermal fillers, people can seem younger without undergoing surgery or a lengthy recovery period. Dermal fillers are drugs that are injected beneath the skin to smooth out wrinkles on the face. The most often used dermal filler drugs include hyaluronic acid, polyalkylimide, calcium hydroxylapatite, polylactic acid, etc. The market’s demand will be increased because of improvements in dermal filler brands.
However, the Asia Pacific dermal fillers treatment market’s growth is constrained by dermal fillers’ side effects, which include redness, swelling, discomfort, bruising, and itching.
ALLERGAN (AbbVie, Inc.), Anika Therapeutics, Inc., Revance Therapeutics, Inc., Bioxis Pharmaceuticals, Merz Pharma, SCULPT Luxury Dermal Fillers LTD, Galderma, Sinclair Pharma, BIOPLUS CO., LTD., DR. Korman, Suneva Medical, Prollenium Medical Technologies, and LG Chem Ltd. are the major market participants in the Asia Pacific Dermal Fillers Treatment Market. Through in-depth investigation, it was discovered that major competitors have used a variety of competitive techniques, including mergers and acquisitions, to seize control of the developing market. Prominent firms are also acquiring small brands in order to enlarge their regional spread.
China dominated the APACA dermal filler treatment industry in terms of share in 2021. This is because both developed and developing nations in the region have expanding disposable incomes and an increased understanding of cosmetic procedures. However, during the course of the prediction, India, and China are projected to demonstrate the highest rate.
Directly Purchase a copy of report with TOC @ https://www.astuteanalytica.com/inquire-before-purchase/asia-pacific-dermal-fillers-treatment-market
The hyaluronic acid segment held a significant share of the APAC dermal fillers treatment industry in 2021. Due to the lower risk of associated allergic responses and the fact that it helps tissues retain water, which keeps them hydrated and lubricated. Contrarily, the fat fillers segment will show the highest annual growth rate throughout the course of the analysis years since it prolongs the appearance of a larger face.
The biodegradable segment held a dominant position in the Asia Pacific dermal fillers treatment industry in the year 2021, and it is anticipated to increase at the highest annual rate during the forecast period. Biodegradable dermal fillers are used because they provide patients with more control over the frequency and duration of procedures. Because temporary fillers are less intrusive, recover faster, and have fewer side effects, the market for biodegradable dermal fillers is growing.
The specialty & dermatology clinics segment, which held the largest market share in the APAC dermal fillers treatment market in 2021, will display a profitable CAGR over the forecasted years. This is because dermatology clinics are the most often used healthcare setting for aesthetic operations. The development of the segment is also due to the growth of dermatological clinics and the accessibility of a wide range of aesthetic treatment choices within the clinics themselves.
By Material Segment
- Hyaluronic Acid
- Calcium Hydroxylapatite
- Poly-L-lactic Acid
- PMMA (Polymethyl methacrylate)
- Collagen Fillers
- Fat Fillers
By Product Segment
By Application Segment
- Scar Treatment
- Wrinkle Correction Treatment
- Lip Enhancement
- Restoration of Volume/ Fullness
- Preorbital Treatment
By End-User Segment
- Specialty & Dermatology Clinics
- Hospitals & Clinics
By Country Segment
- South Korea
- Australia & New Zealand
- Rest of Asia Pacific
To gain more insights into the market with a detailed table of content and figures, click here: https://www.astuteanalytica.com/industry-report/asia-pacific-dermal-fillers-treatment-market
About Astute Analytica
Astute Analytica is a global analytics and advisory company which has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.
BSI Business Park, H-15,Sector-63, Noida- 201301- India
Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)
Follow US: LinkedIn | Twitter